Bar Harbor Trust Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-27,266
Closed -$2.87M 135
2022
Q1
$2.87M Buy
27,266
+3,179
+13% +$310K 0.87% 30
2021
Q4
$2.6M Buy
24,087
+463
+2% +$50.5K 0.7% 39
2021
Q3
$2.59M Buy
23,624
+2,010
+9% +$209K 0.81% 36
2021
Q2
$2.02M Buy
21,614
+1,403
+7% +$129K 0.65% 38
2021
Q1
$1.86M Buy
20,211
+4,917
+32% +$415K 0.68% 36
2020
Q4
$1.12M Buy
15,294
+3,394
+29% +$252K 0.42% 47
2020
Q3
$924K Buy
+11,900
New +$819K 0.39% 50

Other funds holding HZNP

Bar Harbor Trust Services's HZNP Position: Q2 2022 in Review

Bar Harbor Trust Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2022, closing a stake of 27,266 shares — an estimated $2.87M sold.

Bar Harbor Trust Services first reported a position in HZNP in Q3 2020 and held it in 7 quarters. The position peaked at $2.87M in Q1 2022. 616 funds tracked by Wall St. Rank hold HZNP as of Q2 2022.

  • Bar Harbor Trust Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Bar Harbor Trust Services sold 27,266 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2022, an estimated $2.87M.
  • Bar Harbor Trust Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 7 quarters.
  • Bar Harbor Trust Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.87M in Q1 2022.
  • 616 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2022.

Based on Bar Harbor Trust Services's 13F filing for Q2 2022.